Key result
A mosaic PRKACA duplication in a 3-month-old infant caused a novel Carney-like complex phenotype including severe early-onset Cushing's syndrome and acral cutaneous mucinosis.
Why the study?
Pathogenic PRKACA alterations are rarely associated with extra-adrenal phenotypes, unlike PRKAR1A perturbations that cause Carney complex.
Case Report (n=1)
A mosaic PRKACA duplication can cause a novel phenotype of early-onset Cushing's syndrome and acral cutaneous mucinosis, expanding the known extra-adrenal manifestations of PRKACA abnormalities.
Answers are grounded in this paper and cite their sources.
May prompt PRKACA testing in early-onset Cushing syndrome; hypothesis-generating for expanded Carney-like phenotypes.
Genetic alterations within the cAMP/protein kinase A (PKA) pathway result in a spectrum of adrenocortical disorders. Implicated genes include GNAS, PDE8B, PDE11A, PRKAR1A/B, and PRKACA. To date, pathogenic somatic PRKACA variants and germline PRKACA copy number gain have been associated with the development of cortisol-secreting adrenocortical adenomas and bilateral adrenal hyperplasia, respectively. While perturbations within the PRKAR1A gene are known to cause Carney complex, PKRACA mutations are rarely associated with an extra-adrenal phenotype. We describe a mosaic PRKACA duplication in an infant who presented with a Carney-like complex at the age of 3 months with bilateral non-pigmented micronodular adrenal hyperplasia, severe early-onset Cushing's syndrome, and distinct acral soft tissue overgrowth due to cutaneous mucinosis. This represents a novel manifestation of PRKACA disruption and broadens its extra-adrenal phenotype. It suggests that the Cushing's syndrome phenotypes arising from somatic and germline PRKACA abnormalities likely exist on a spectrum. We emphasise the importance of ascertaining a genetic diagnosis for PRKACA-mediated disease. Significance statement We describe a mosaic PRKACA duplication in a young infant who presented with a Carney-like complex: bilateral non-pigmented micronodular adrenal hyperplasia, severe early-onset Cushing's syndrome, and distinct acral soft tissue overgrowth due to cutaneous mucinosis. This represents a novel manifestation of PRKACA disruption and broadens the extra-adrenal phenotype of PRKACA-associated Cushing's syndrome. Our data suggest that Cushing's syndrome phenotypes arising from somatic and germline PRKACA abnormalities can exist on a spectrum. We emphasise the value of ascertaining a genetic diagnosis for PRKACA-mediated adrenal and extra-adrenal disease to guide individualised and targeted care.
No takes yet. Share an insight, caveat, or question.
McGlacken‐Byrne et al. (2022) conducted a case report in Cushing's syndrome and acral cutaneous mucinosis (n=1). Mosaic PRKACA duplication was evaluated on Clinical phenotype. A mosaic PRKACA duplication in a 3-month-old infant caused a novel Carney-like complex phenotype including severe early-onset Cushing's syndrome and acral cutaneous mucinosis.
Synapse has enriched 10 related papers. Consider them for comparative context: